Suvaxyn Circo+MH RTU


Porcine circovirus and porcine enzootic pneumonia vaccine (inactivated)

This medicine is authorised for use in the European Union.


This is a summary of the European public assessment report (EPAR) for Suvaxyn Circo+MH RTU.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Suvaxyn Circo+MH RTU.

For practical information about using Suvaxyn Circo+MH RTU, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 03/11/2021

Authorisation details

Product details
Suvaxyn Circo+MH RTU
Agency product number
Active substance
  • Inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 ORF2 protein
  • Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
International non-proprietary name (INN) or common name
Porcine circovirus and porcine enzootic pneumonia vaccine (inactivated)
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve

Product information

14/10/2021 Suvaxyn Circo+MH RTU - EMEA/V/C/003924 - IB-0018

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Inactivated viral and inactivated bacterial vaccines

Therapeutic indication

For active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (PCV2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused by infection with PCV2.

For active immunisation of pigs over the age of 3 weeks against Mycoplasma hyopneumoniae to reduce lung lesions caused by infection with M. hyopneumoniae.

Assessment history

How useful was this page?

Add your rating
1 rating